NAD+ activates DNA repair enzymes, but oxidative damage can accumulate faster than repair can keep pace when glutathione is low
Nu hi c lm trng da khng, cu tr li ca mnh l c h tr lm sng da, nhng theo kiu t t v thin v ci thin xn mu hn l trng hn
Possible side effects can include allergic reactions, infection at the site of infusion, and vein irritation
Interpretable architecture (or post hoc explainers) can identify the main drivers of recommendations (e.g., SHAP-based feature attributions)
Mild side effects may include redness, swelling, or slight bruising at the injection site
The Reuters report on a head-to-head trial against tirzepatide (February 2026) noted CagriSema did not meet a non-inferiority threshold against tirzepatide on average weight loss at 84 weeks